Research Article
Open Access
TICAM-1/TRIF associates with Act1 and suppresses IL-17 receptor–mediated inflammatory responses
View ORCID ProfileYusuke Miyashita, Takahisa Kouwaki, View ORCID ProfileHirotake Tsukamoto Correspondence email, View ORCID ProfileMasaaki Okamoto, View ORCID ProfileKimitoshi Nakamura, View ORCID ProfileHiroyuki Oshiumi Correspondence email
Yusuke Miyashita
1Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, Japan
2Department of Pediatrics, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, Japan
Roles: Data curation, Formal analysis, Validation, Investigation, Writing—original draft, review, and editing
Takahisa Kouwaki
1Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, Japan
Roles: Data curation, Investigation
Hirotake Tsukamoto
1Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, Japan
3Division of Clinical Immunology and Cancer Immunotherapy, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Roles: Data curation, Supervision, Investigation, Writing—original draft, review, and editing
Masaaki Okamoto
1Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, Japan
Roles: Data curation, Investigation
Kimitoshi Nakamura
2Department of Pediatrics, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, Japan
Roles: Conceptualization, Supervision, Project administration
Hiroyuki Oshiumi
1Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, Japan
Roles: Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing—original draft, review, and editing
Published 24 November 2021. DOI: 10.26508/lsa.202101181
TICAM-1 is a negative regulator of IL-17RA signaling
Yusuke Miyashita, Takahisa Kouwaki, Hirotake Tsukamoto, Masaaki Okamoto, Kimitoshi Nakamura, Hiroyuki Oshiumi
Life Science Alliance Nov 2021, 5 (2) e202101181; DOI: 10.26508/lsa.202101181
In this Issue
Volume 5, No. 2
February 2022
Advertisement
Jump to section
Related Articles
- No related articles found.